Skip to main navigation Skip to search Skip to main content

Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices

  • Alan P. Skarbnik
  • , Esprit Ma
  • , Marie Hélène Lafeuille
  • , Jonathan Fortier
  • , Tatyana Feldman
  • , Mei Sheng Duh
  • , Helgi van de Velde
  • , Liviu Niculescu
  • , Vijayveer Bonthapally
  • , André Goy
  • Rutgers - The State University of New Jersey, Newark
  • Takeda Pharmaceutical Company Limited
  • Ltée
  • Analysis Group, Inc.

Research output: Contribution to journal › Editorial

4 Scopus citations
Original languageEnglish
Pages (from-to)1968-1972
Number of pages5
JournalLeukemia and Lymphoma
Volume58
Issue number8
DOIs
StatePublished - 3 Aug 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this